Table 5.
Patients were classified into two groups as those treated with biological agents and conventional agents. No significant difference was observed in the achieving of PASI 75 and PASI 90 responses during the first and third months
| BIOLOGICAL | CONVENTIONAL | |||||
|---|---|---|---|---|---|---|
| BMI <30 (N=157) | BMI >30 (N=65) | P | BMI <30 (N=67) | BMI >30 (N=28) | P | |
| PASI 75 during the first month | 49.0% (N=77) | 40.0% (N=26) | 0.239 | 13.4% (N=9) | 3.6% (N=1) | 0.272 |
| PASI 90 during the first month | 33.8% (N=53) | 33.8% (N=22) | 1.000 | 9.0% (N=6) | 0.0% (N=0) | 0.175 |
| PASI 75 during the third month | 70.1% (N=110) | 55.4% (N=36) | 0.044 | 29.9% (N=20) | 25.0% (N=7) | 0.804 |
| PASI 90 during the third month | 58.6% (N=92) | 44.6% (N=29) | 0.075 | 23.9% (N=16) | 3.6% (N=1) | 0.014 |
BMI = body mass index; PASI = Psoriasis Area and Severity Index.